Glucocorticoid receptor expression in multiple myeloma patients is a predictor of survival.

Alexander Pozhitkov, Michael Rosenzweig, Flavia Pichiorri, Emine G Gunes, Ralf Buettner, Jonathan J Keats, Steven T Rosen

Leukemia & lymphoma 2020 Dec

filter terms:

Multiple myeloma (MM) is a blood neoplasia characterized by abnormal proliferation of plasma cells. Various treatments such as stem cell transplant (SCT), proteasome inhibitors, immune-modulating drugs, monoclonal antibodies and selective inhibitors of nuclear export have been routinely used to treat MM. However, relapse and treatment resistance are common problems in MM patients. Treatments are enhanced by Dexamethasone (Dex), a synthetic steroid that activates the glucocorticoid receptor (GR) which leads to apoptosis. To evaluate the potential impact of GR expression on overall survival, MM patient data from the CoMMpass study of 650 patients were analyzed. Multivariate modeling results show that increased GR expression at diagnosis is associated with a decreased risk of dying relative to those with lower levels of expression.

Citation

Alexander Pozhitkov, Michael Rosenzweig, Flavia Pichiorri, Emine G Gunes, Ralf Buettner, Jonathan J Keats, Steven T Rosen. Glucocorticoid receptor expression in multiple myeloma patients is a predictor of survival. Leukemia & lymphoma. 2020 Dec;61(14):3493-3497